Veterans

Alleva Introduces InCheck: Transforming Behavioral Health Compliance Into a Year-Round System

LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced InCheck, a comprehensive compliance management…

2 months ago

Alleva Introduces InCheck: Transforming Behavioral Health Compliance Into a Year-Round System

LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced InCheck, a comprehensive compliance management…

2 months ago

Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer

Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public…

2 months ago

Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer

Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public…

2 months ago

ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov

MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare…

2 months ago

ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov

MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare…

2 months ago

The Great American Elderverse™ Comes to Texas

Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower…

2 months ago

The Great American Elderverse™ Comes to Texas

Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower…

2 months ago

Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic

REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in…

2 months ago

Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic

REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in…

2 months ago